BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 69 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $151,000 | -61.0% | 2,064 | -70.9% | 0.04% | -44.7% |
Q4 2019 | $387,000 | +219.8% | 7,104 | +145.0% | 0.08% | +145.2% |
Q3 2019 | $121,000 | -9.7% | 2,900 | +11.5% | 0.03% | +72.2% |
Q1 2019 | $134,000 | +538.1% | 2,600 | +333.3% | 0.02% | +157.1% |
Q4 2018 | $21,000 | -78.6% | 600 | -76.9% | 0.01% | -61.1% |
Q3 2018 | $98,000 | +63.3% | 2,600 | +8.3% | 0.02% | +100.0% |
Q2 2017 | $60,000 | – | 2,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |